Dier Mardi bought MDGL
March 4, 2026 · Form 4 insider transaction
Dier Mardi bought 5,215 shares of Madrigal Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,215
Price
$0.00
Total value
N/A
InsiderDier Mardi
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 4, 2026
Filing dateMarch 6, 2026
Shares owned after14,472
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.